THAR
Tharimmune, Inc. - Common Stock (THAR)
$45
About Tharimmune, Inc. - Common Stock (THAR)
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Details
Daily high
$2.49
Daily low
$2.38
Price at open
$2.49
52 Week High
$9.08
52 Week Low
$0.95
Market cap
90.7M
Dividend yield
0.00%
Volume
264,782
Avg. volume
374,042
P/E ratio
-.64
Tharimmune, Inc. - Common Stock News
Details
Daily high
$2.49
Daily low
$2.38
Price at open
$2.49
52 Week High
$9.08
52 Week Low
$0.95
Market cap
90.7M
Dividend yield
0.00%
Volume
264,782
Avg. volume
374,042
P/E ratio
-.64